EpiCast Report: Chronic Kidney Disease – Epidemiology Forecast to 2026
Chronic kidney disease CKD, or chronic renal disease, is an asymptomatic, longterm condition that damages the kidneys and leads to the loss of kidney function over time NIH, 2010. As the disease progresses, the symptoms worsen, eventually leading to kidney failure NIH, 2010. The glomerular filtration rate GFR, a key measure of kidney function, is determined by the amount of creatinine in the blood, and the Kidney Disease, Improving Global Outcomes KDIGO classification system is considered the standard for GFR measurement and diagnosis of CKD.
Download FREE Sample of this Report @ https://www.24marketreports.com/report-sample/epicast-report-chronic-kidney-disease—epidemiology-forecast-to-2026-market-68
GlobalData epidemiologists provide a 10year epidemiological forecast for the total prevalent cases including both diagnosed and undiagnosed cases of CKD Stages IIV by age and sex, the total prevalent cases of CKD by stage, the diagnosed prevalent cases of CKD Stages IV, and the diagnosed prevalent cases of CKD by stage.
In the 7MM, GlobalData epidemiologists forecast the diagnosed prevalent cases of CKD, Stages IV, to increase from 25,775,828 cases in 2016 to 28,325,839 cases in 2026, at an Annual Growth Rate AGR of 0.99%. The UK will have the highest number of diagnosed cases of CKD throughout the forecast period.
Scope
The Chronic Kidney Disease EpiCast Report provides an overview of the risk factors and global trends of chronic kidney disease in the seven major markets 7MM: US, France, Germany, Italy, Spain, UK, and Japan.
This report also includes a 10year epidemiological forecast for the total prevalent cases of CKD, Stages IIV, segmented by age beginning at 20 years and ending at ages 80 years and older, by sex, and by stage. Furthermore, this report includes a forecast of the diagnosed prevalent cases of CKD, Stages IV, and the diagnosed prevalent cases of CKD by stage.
The chronic kidney disease epidemiology report is written and developed by Masters and PhDlevel epidemiologists.
The EpiCast Report is indepth, high quality, transparent and marketdriven, providing expert analysis of disease trends in the 7MM.
Reasons to buy
The Chronic Kidney Disease EpiCast report will allow you to
Develop business strategies by understanding the trends shaping and driving the global chronic kidney disease treatment market.
Quantify patient populations in the chronic kidney disease market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for chronic kidney disease therapeutics in each of the markets covered.
Understand magnitude of chronic kidney disease.
Get the Complete Report & TOC @ https://www.24marketreports.com/life-sciences/epicast-report-chronic-kidney-disease—epidemiology-forecast-to-2026-market-68
Table of content
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Chronic Kidney Disease: Executive Summary 4
2.1 Related Reports 5
2.2 Upcoming Reports 6
3 Epidemiology 7
3.1 Disease Background 7
3.2 Risk Factors and Comorbidities 8
3.3 Global and Historical Trends 8
3.4 Forecast Methodology 9
3.4.1 Sources 10
3.4.2 Forecast Assumptions and Methods 14
3.5 Epidemiological Forecast for CKD 20162026 20
3.5.1 Total Prevalent Cases of CKD, Stages IIV 20
3.5.2 AgeSpecific Total Prevalent Cases of CKD, Stages IIV 20
3.5.3 SexSpecific Total Prevalent Cases of CKD, Stages IIV 21
3.5.4 Total Prevalent Cases of CKD by Stage 22
3.5.5 Diagnosed Prevalent Cases of CKD, Stages IV 23
3.5.6 Diagnosed Prevalent Cases of CKD by Stage 24
3.6 Discussion 25
3.6.1 Epidemiological Forecast Insight 25
3.6.2 Limitations of the Analysis 26
3.6.3 Strengths of the Analysis 26
If You Have Any Question Related To This Report Contact Us @ https://www.24marketreports.com/enquire-now/epicast-report-chronic-kidney-disease—epidemiology-forecast-to-2026-market-68
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Fax: (+1) 212 634 4885
Email: [email protected]
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports